Related Experiment Video

Updated: Jul 14, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

Secondary prevention for patients following a myocardial infarction: summary of NICE guidance

J S Skinner1, A Cooper, G S Feder

  • 1Department of Cardiology, Royal Victoria Infirmary, Newcastle upon Tyne, UK. Jane.Skinner@nuth.nhs.uk

Heart (British Cardiac Society)
|June 16, 2007
PubMed

Insights

New guidelines offer improved secondary prevention strategies for patients following myocardial infarction (heart attack). These evidence-based recommendations aim to reduce coronary heart disease mortality in the UK.

Area of Science:

  • Cardiology
  • Public Health
  • Evidence-Based Medicine

Background:

  • Coronary heart disease (CHD) mortality in the UK has declined since the 1970s but remains elevated compared to other Western nations.
  • While many patients receive secondary prevention post-myocardial infarction (MI), optimal treatment packages are not universally applied.
  • Existing guidelines require updating to reflect the latest evidence in secondary prevention.

Purpose of the Study:

  • To summarize the recently published NICE guideline for secondary prevention after myocardial infarction.
  • To highlight updated and expanded recommendations for patient management.
  • To provide healthcare professionals with evidence-based guidance for improving post-MI care.

Main Methods:

  • Review and summarization of the latest NICE guideline.
  • Analysis of evidence supporting updated recommendations.
  • Focus on key areas including lifestyle modifications and pharmacotherapy.

Main Results:

  • The updated NICE guideline provides clear recommendations for post-MI secondary prevention.
  • Expanded emphasis on physical activity, dietary changes, lifestyle modifications, and cardiac rehabilitation.
  • Updated drug therapy recommendations based on current evidence.

Conclusions:

  • The new guideline offers a comprehensive, evidence-based approach to secondary prevention after MI.
  • Implementation of these recommendations can help reduce CHD mortality and improve patient outcomes.
  • Healthcare providers should adhere to the updated guidelines for optimal patient care.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...